Triple
T22306635
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | John C. Martin |
E551391
|
entity |
| Predicate | notableWork |
P4
|
FINISHED |
| Object | leadership in development of hepatitis C antiviral regimens at Gilead Sciences |
—
|
LITERAL FINISHED |
Provenance (2 batches)
| Stage | Batch ID | Job type | Status |
|---|---|---|---|
| creating | batch_69e11e46c0188190800181a4233f28fe |
elicitation | completed |
| NER | batch_69f157276d3c8190a55c93760a986cdc |
ner | completed |
Created at: April 16, 2026, 8:41 p.m.